Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel
Condition(s):Malignant GliomaLast Updated:August 3, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Malignant GliomaLast Updated:August 3, 2022Completed
Condition(s):GliomaLast Updated:October 11, 2023Recruiting
Condition(s):GliomaLast Updated:January 23, 2018Unknown status
Condition(s):High-grade GliomaLast Updated:August 21, 2023Not yet recruiting
Condition(s):Glioma of BrainLast Updated:September 29, 2023Active, not recruiting
Condition(s):Glioma, MalignantLast Updated:January 12, 2024Recruiting
Condition(s):GliomaLast Updated:February 8, 2024Withdrawn
Condition(s):Glioma of Brain; CAR-T Cell ImmunotherapyLast Updated:July 16, 2020Withdrawn
Condition(s):GliomaLast Updated:October 19, 2021Completed
Condition(s):Glioblastoma; Anaplastic Astrocytoma; Astrocytoma; Anaplastic OligodendrogliomaLast Updated:February 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.